Melatonin reduces low-Mg2+ epileptiform activity in human temporal slices. 1995

J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
Institut für Anatomie, Universität Münster, Germany.

Seizure susceptibility waxes and wanes in an apparently circadian manner in many epileptic patients. Fluctuations of melatonin concentration with highest levels during the night and lowest levels in the early morning could be involved in this phenomenon. Therefore, the action of melatonin on epileptic activity was tested. The experiments were carried out on human temporal neocortical slices cut from tissue resected for surgical treatment of epilepsy. Autoradiographic studies were performed on parallel slices with 100-120 pmol 2-[125I]iodomelatonin/l in the absence or presence of unlabelled melatonin. High-affinity binding sites of melatonin could be demonstrated in layers II-V of the temporal cortex. The binding was saturable, specific and occurred with low capacity. In electrophysiological studies, epileptiform field potentials were elicited by omission of Mg2+ from the superfusate and recorded from layers II-V. The frequency of occurrence of epileptiform field potentials was reduced to 0.5 of the initial value with application of melatonin (10 and 100 nmol/l) in each case. This effect was reversible upon washing. The findings favour the hypothesis that melatonin depresses epileptiform neuronal activity through specific neocortical receptors.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D013702 Temporal Lobe Lower lateral part of the cerebral hemisphere responsible for auditory, olfactory, and semantic processing. It is located inferior to the lateral fissure and anterior to the OCCIPITAL LOBE. Anterior Temporal Lobe,Brodmann Area 20,Brodmann Area 21,Brodmann Area 22,Brodmann Area 37,Brodmann Area 38,Brodmann Area 52,Brodmann's Area 20,Brodmann's Area 21,Brodmann's Area 22,Brodmann's Area 37,Brodmann's Area 38,Brodmann's Area 52,Inferior Temporal Gyrus,Middle Temporal Gyrus,Parainsular Area,Fusiform Gyrus,Gyrus Fusiformis,Gyrus Temporalis Superior,Inferior Horn of Lateral Ventricle,Inferior Horn of the Lateral Ventricle,Lateral Occipito-Temporal Gyrus,Lateral Occipitotemporal Gyrus,Occipitotemporal Gyrus,Planum Polare,Superior Temporal Gyrus,Temporal Cortex,Temporal Gyrus,Temporal Horn,Temporal Horn of the Lateral Ventricle,Temporal Operculum,Temporal Region,Temporal Sulcus,Anterior Temporal Lobes,Area 20, Brodmann,Area 20, Brodmann's,Area 21, Brodmann,Area 21, Brodmann's,Area 22, Brodmann,Area 22, Brodmann's,Area 37, Brodmann,Area 37, Brodmann's,Area 38, Brodmann,Area 38, Brodmann's,Area 52, Brodmann,Area 52, Brodmann's,Area, Parainsular,Areas, Parainsular,Brodmanns Area 20,Brodmanns Area 21,Brodmanns Area 22,Brodmanns Area 37,Brodmanns Area 38,Brodmanns Area 52,Cortex, Temporal,Gyrus, Fusiform,Gyrus, Inferior Temporal,Gyrus, Lateral Occipito-Temporal,Gyrus, Lateral Occipitotemporal,Gyrus, Middle Temporal,Gyrus, Occipitotemporal,Gyrus, Superior Temporal,Gyrus, Temporal,Horn, Temporal,Lateral Occipito Temporal Gyrus,Lobe, Anterior Temporal,Lobe, Temporal,Occipito-Temporal Gyrus, Lateral,Occipitotemporal Gyrus, Lateral,Operculum, Temporal,Parainsular Areas,Region, Temporal,Sulcus, Temporal,Temporal Cortices,Temporal Gyrus, Inferior,Temporal Gyrus, Middle,Temporal Gyrus, Superior,Temporal Horns,Temporal Lobe, Anterior,Temporal Lobes,Temporal Lobes, Anterior,Temporal Regions
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
January 1999, Brain research,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
January 1991, Experimental brain research,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
January 2010, Brain research,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
October 2002, Neurobiology of disease,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
August 2008, Brain research,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
July 1995, Brain research. Developmental brain research,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
June 2019, Journal of neural engineering,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
April 2006, Synapse (New York, N.Y.),
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
August 2000, European journal of pharmacology,
J D Fauteck, and J Bockmann, and T M Böckers, and W Wittkowski, and R Köhling, and A Lücke, and H Straub, and E J Speckmann, and I Tuxhorn, and P Wolf
February 2019, Research in pharmaceutical sciences,
Copied contents to your clipboard!